Last 12 months
Inside the activity.
4 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 3 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 15, 2020 Filed Nov 16, 2020 22:50 UTC |
Kimpe MarcSVP, Research & Development
|
Tax withholdingCommon Stock | 691 | $12.65 | $8,741.15 |
DisclosureSEC source: 0000926282-20-000031 · primary_doc.xml · nonDerivative · entry 2 Kimpe Marc · CIK 0001770330 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,544 Read SEC document |
| November 15, 2020 Filed Nov 16, 2020 19:50 UTC |
Centis RonaldSVP, Operations
|
Tax withholdingCommon Stock | 726 | $12.65 | $9,183.90 |
DisclosureSEC source: 0000926282-20-000029 · primary_doc.xml · nonDerivative · entry 1 Centis Ronald · CIK 0001769038 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,049.76 Read SEC document |
| November 15, 2020 Filed Nov 16, 2020 20:39 UTC |
Scheiterer EduardSVP, Research & Development
|
Tax withholdingCommon Stock | 677 | $12.65 | $8,564.05 |
DisclosureSEC source: 0000926282-20-000030 · primary_doc.xml · nonDerivative · entry 2 Scheiterer Eduard · CIK 0001628537 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,077 Read SEC document |
| November 15, 2020 Filed Nov 16, 2020 19:26 UTC |
STANTON THOMAS RDirector · Chairman and CEO
|
Tax withholdingCommon Stock | 6,154 | $12.65 | $77,848.10 |
DisclosureSEC source: 0000926282-20-000026 · primary_doc.xml · nonDerivative · entry 2 STANTON THOMAS R · CIK 0001191219 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,437 Read SEC document |
| November 15, 2020 Filed Nov 16, 2020 19:35 UTC |
Wilson James Denson JrChief Revenue Officer
|
Tax withholdingCommon Stock | 1,086 | $12.65 | $13,737.90 |
DisclosureSEC source: 0000926282-20-000027 · primary_doc.xml · nonDerivative · entry 2 Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,364 Read SEC document |
| November 15, 2020 Filed Nov 16, 2020 19:42 UTC |
Foliano MichaelChief Financial Officer
|
Tax withholdingCommon Stock | 1,070 | $12.65 | $13,535.50 |
DisclosureSEC source: 0000926282-20-000028 · primary_doc.xml · nonDerivative · entry 2 Foliano Michael · CIK 0001300513 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,644 Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 22:50 UTC |
Kimpe MarcSVP, Research & Development
|
Tax withholdingCommon Stock | 259 | $12.39 | $3,208.47 |
DisclosureSEC source: 0000926282-20-000031 · primary_doc.xml · nonDerivative · entry 1 Kimpe Marc · CIK 0001770330 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,235 Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 20:39 UTC |
Scheiterer EduardSVP, Research & Development
|
Tax withholdingCommon Stock | 312 | $12.33 | $3,846.96 |
DisclosureSEC source: 0000926282-20-000030 · primary_doc.xml · nonDerivative · entry 1 Scheiterer Eduard · CIK 0001628537 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,754 Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 19:26 UTC |
STANTON THOMAS RDirector · Chairman and CEO
|
Tax withholdingCommon Stock | 2,134 | $12.33 | $26,312.22 |
DisclosureSEC source: 0000926282-20-000026 · primary_doc.xml · nonDerivative · entry 1 STANTON THOMAS R · CIK 0001191219 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,591 Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 19:35 UTC |
Wilson James Denson JrChief Revenue Officer
|
Tax withholdingCommon Stock | 475 | $12.33 | $5,856.75 |
DisclosureSEC source: 0000926282-20-000027 · primary_doc.xml · nonDerivative · entry 1 Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,450 Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 19:42 UTC |
Foliano MichaelChief Financial Officer
|
Tax withholdingCommon Stock | 375 | $12.33 | $4,623.75 |
DisclosureSEC source: 0000926282-20-000028 · primary_doc.xml · nonDerivative · entry 1 Foliano Michael · CIK 0001300513 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,714 Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 00:56 UTC |
Scheiterer EduardSVP, Research & Development
|
Tax withholdingCommon Stock | 269 | $12.51 | $3,365.19 |
DisclosureSEC source: 0000926282-20-000024 · primary_doc.xml · nonDerivative · entry 2 Scheiterer Eduard · CIK 0001628537 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,066 Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 01:03 UTC |
Kimpe MarcSVP, Research & Development
|
Tax withholdingCommon Stock | 257 | $12.51 | $3,215.07 |
DisclosureSEC source: 0000926282-20-000025 · primary_doc.xml · nonDerivative · entry 2 Kimpe Marc · CIK 0001770330 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,494 Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 00:48 UTC |
Wilson James Denson JrChief Revenue Officer
|
Tax withholdingCommon Stock | 431 | $12.51 | $5,391.81 |
DisclosureSEC source: 0000926282-20-000023 · primary_doc.xml · nonDerivative · entry 2 Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,925 Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 00:41 UTC |
Foliano MichaelChief Financial Officer
|
Tax withholdingCommon Stock | 327 | $12.51 | $4,090.77 |
DisclosureSEC source: 0000926282-20-000022 · primary_doc.xml · nonDerivative · entry 2 Foliano Michael · CIK 0001300513 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,089 Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 00:24 UTC |
STANTON THOMAS RDirector · Chairman and CEO
|
Tax withholdingCommon Stock | 2,003 | $12.51 | $25,057.53 |
DisclosureSEC source: 0000926282-20-000021 · primary_doc.xml · nonDerivative · entry 2 STANTON THOMAS R · CIK 0001191219 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,725 Read SEC document |
| November 11, 2020 Filed Dec 3, 2020 21:22 UTC Amendment |
STANTON THOMAS RDirector · Chairman and CEO
|
GrantPhantom Stock · Derivative | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000047 · primary_doc.xml · derivative · entry 4 STANTON THOMAS R · CIK 0001191219 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,830.706 Underlying: Common Stock · 0 shares Expires not disclosed F1 · derivative.exercise_price: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 18,702 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction. F1 · shares: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 18,702 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction. F1 · derivative.exercise_date: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 18,702 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction. F1 · derivative.expiration_date: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 18,702 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction. F1 · derivative.underlying_shares: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 18,702 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction. F1 · balance_after: On November 18, 2020, the reporting person filed a Form 4 incorrectly reporting the acquisition of 18,702 shares of phantom stock on November 16, 2020, which shares should have been reported as the acquisition of shares of common stock. In addition to correcting such transaction, this amendment shows the correct number of shares of common stock (as outlined in Table I) and phantom stock (as outlined in Table II) owned by the reporting person after such transaction. Read SEC document |
| November 11, 2020 Filed Dec 3, 2020 21:22 UTC Amendment |
STANTON THOMAS RDirector · Chairman and CEO
|
Tax withholdingCommon Stock | 8,295 | $12.51 | $103,770.45 |
DisclosureSEC source: 0000926282-20-000047 · primary_doc.xml · nonDerivative · entry 2 STANTON THOMAS R · CIK 0001191219 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,090 Read SEC document |
| November 11, 2020 Filed Dec 3, 2020 17:36 UTC |
Scheiterer EduardSVP, Research & Development
|
Tax withholdingCommon Stock | 738 | $12.51 | $9,232.38 |
DisclosureSEC source: 0000926282-20-000046 · primary_doc.xml · nonDerivative · entry 1 Scheiterer Eduard · CIK 0001628537 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,578 Read SEC document |
| November 09, 2020 Filed Nov 13, 2020 00:56 UTC |
Scheiterer EduardSVP, Research & Development
|
Tax withholdingCommon Stock | 421 | $11.77 | $4,955.17 |
DisclosureSEC source: 0000926282-20-000024 · primary_doc.xml · nonDerivative · entry 1 Scheiterer Eduard · CIK 0001628537 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,335 Read SEC document |
| November 09, 2020 Filed Nov 13, 2020 01:03 UTC |
Kimpe MarcSVP, Research & Development
|
Tax withholdingCommon Stock | 404 | $11.77 | $4,755.08 |
DisclosureSEC source: 0000926282-20-000025 · primary_doc.xml · nonDerivative · entry 1 Kimpe Marc · CIK 0001770330 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,751 Read SEC document |
| November 09, 2020 Filed Nov 13, 2020 00:48 UTC |
Wilson James Denson JrChief Revenue Officer
|
Tax withholdingCommon Stock | 674 | $11.77 | $7,932.98 |
DisclosureSEC source: 0000926282-20-000023 · primary_doc.xml · nonDerivative · entry 1 Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,356 Read SEC document |
| November 09, 2020 Filed Nov 13, 2020 00:41 UTC |
Foliano MichaelChief Financial Officer
|
Tax withholdingCommon Stock | 511 | $11.77 | $6,014.47 |
DisclosureSEC source: 0000926282-20-000022 · primary_doc.xml · nonDerivative · entry 1 Foliano Michael · CIK 0001300513 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,416 Read SEC document |
| November 09, 2020 Filed Nov 13, 2020 00:24 UTC |
STANTON THOMAS RDirector · Chairman and CEO
|
Tax withholdingCommon Stock | 3,130 | $11.77 | $36,840.10 |
DisclosureSEC source: 0000926282-20-000021 · primary_doc.xml · nonDerivative · entry 1 STANTON THOMAS R · CIK 0001191219 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,728 Read SEC document |
| September 09, 2020 Filed Sep 10, 2020 14:36 UTC |
McCray Gregory JamesDirector
|
GrantCommon Stock | 64.32 | $10.34 | $665.07 |
DisclosureSEC source: 0000926282-20-000018 · primary_doc.xml · nonDerivative · entry 1 McCray Gregory James · CIK 0001327057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,180.437 F1 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock. Read SEC document |
| September 09, 2020 Filed Sep 16, 2020 15:55 UTC |
Centis RonaldSVP, Operations
|
GrantCommon Stock | 3.077 | $10.34 | $31.82 |
DisclosureSEC source: 0000926282-20-000020 · primary_doc.xml · nonDerivative · entry 2 Centis Ronald · CIK 0001769038 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,775.759 F1 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock. Read SEC document |
| September 09, 2020 Filed Sep 16, 2020 15:49 UTC |
Harris RayChief Information Officer
|
GrantCommon Stock | 2.917 | $10.34 | $30.16 |
DisclosureSEC source: 0000926282-20-000019 · primary_doc.xml · nonDerivative · entry 3 Harris Ray · CIK 0001766181 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,941.097 F1 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock. Read SEC document |
| September 03, 2020 Filed Sep 4, 2020 21:36 UTC | GrantPhantom Stock · Derivative | 143.618 | $0.00 | $0.00 |
DisclosureSEC source: 0001300513-20-000001 · primary_doc.xml · derivative · entry 2 Foliano Michael · CIK 0001300513 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,367.349 Underlying: Common Stock · 143.618 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock at the cash value thereof. F3 · derivative.exercise_date: Phantom stock held in a deferred compensation plan by the Reporting Person, which becomes payable six months after the Reporting Person's separation of service with the Company. The Reporting Person may transfer the phantom stock into an alternative investment at any time. F3 · derivative.expiration_date: Phantom stock held in a deferred compensation plan by the Reporting Person, which becomes payable six months after the Reporting Person's separation of service with the Company. The Reporting Person may transfer the phantom stock into an alternative investment at any time. Read SEC document |
|
| September 03, 2020 Filed Sep 4, 2020 21:36 UTC | GrantCommon Stock | 1.974 | $0.00 | $0.00 |
DisclosureSEC source: 0001300513-20-000001 · primary_doc.xml · nonDerivative · entry 1 Foliano Michael · CIK 0001300513 · CFO 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) Plan Disclosed balance after: 239.808 F1 · date: Dividends reinvested into common stock and held in 401(k) plan by Reporting Person. Read SEC document |
|
| September 03, 2020 Filed Sep 4, 2020 19:41 UTC |
STANTON THOMAS RChairman and CEO
|
GrantPhantom Stock · Derivative | 817.271 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000011 · primary_doc.xml · derivative · entry 1 STANTON THOMAS R · CIK 0001191219 · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,830.706 Underlying: Common Stock · 817.271 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock at the cash value thereof. F2 · derivative.exercise_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time. F2 · derivative.expiration_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 15:30 UTC |
NICHOLS ROY JDirector
|
GrantDividend Equivalent Rights · Derivative | 79.235 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000014 · primary_doc.xml · derivative · entry 1 NICHOLS ROY J · CIK 0000937725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253.378 Underlying: Common Stock · 79.235 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 19:48 UTC |
McCray Gregory JamesDirector
|
GrantDividend Equivalent Rights · Derivative | 79.235 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000017 · primary_doc.xml · derivative · entry 2 McCray Gregory James · CIK 0001327057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253.378 Underlying: Common Stock · 79.235 shares Expires not disclosed F2 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F2 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F2 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 19:34 UTC |
Jacqueline Hourigan RiceDirector
|
GrantDividend Equivalent Rights · Derivative | 79.235 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000015 · primary_doc.xml · derivative · entry 1 Jacqueline Hourigan Rice · CIK 0001637150 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253.378 Underlying: Common Stock · 79.235 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 19:38 UTC |
Walker Kathryn ADirector
|
GrantDividend Equivalent Rights · Derivative | 79.235 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000016 · primary_doc.xml · derivative · entry 1 Walker Kathryn A · CIK 0001264261 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253.378 Underlying: Common Stock · 79.235 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 19:25 UTC |
Nair BalanDirector
|
GrantDividend Equivalent Rights · Derivative | 79.235 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000013 · primary_doc.xml · derivative · entry 1 Nair Balan · CIK 0001398905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253.378 Underlying: Common Stock · 79.235 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 19:21 UTC |
HUSS H FENWICKDirector
|
GrantDividend Equivalent Rights · Derivative | 79.235 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000012 · primary_doc.xml · derivative · entry 1 HUSS H FENWICK · CIK 0001201037 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253.378 Underlying: Common Stock · 79.235 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 12:55 UTC |
Wilson James Denson JrChief Revenue Officer
|
GrantPhantom Stock · Derivative | 137.389 | $0.00 | $0.00 |
DisclosureSEC source: 0001300513-20-000002 · primary_doc.xml · derivative · entry 3 Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,614.21 Underlying: Common Stock · 137.389 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock at the cash value thereof. F3 · derivative.exercise_date: Phantom stock held in a deferred compensation plan by the Reporting Person, which becomes payable six months after the Reporting Person's separation of service with the Company. The Reporting Person may transfer the phantom stock into an alternative investment at any time. F3 · derivative.expiration_date: Phantom stock held in a deferred compensation plan by the Reporting Person, which becomes payable six months after the Reporting Person's separation of service with the Company. The Reporting Person may transfer the phantom stock into an alternative investment at any time. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 12:55 UTC |
Wilson James Denson JrChief Revenue Officer
|
GrantCommon Stock | 32.776 | $0.00 | $0.00 |
DisclosureSEC source: 0001300513-20-000002 · primary_doc.xml · nonDerivative · entry 2 Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) Plan Disclosed balance after: 3,982.121 F1 · security: Dividends reinvested into common stock and held in 401(k) plan by Reporting Person. Read SEC document |
| June 09, 2020 Filed Sep 8, 2020 19:48 UTC |
McCray Gregory JamesDirector
|
GrantCommon Stock | 56.049 | $11.78 | $660.26 |
DisclosureSEC source: 0000926282-20-000017 · primary_doc.xml · nonDerivative · entry 1 McCray Gregory James · CIK 0001327057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,116.12 F1 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock. Read SEC document |
| June 09, 2020 Filed Sep 16, 2020 15:55 UTC |
Centis RonaldSVP, Operations
|
GrantCommon Stock | 2.682 | $11.78 | $31.59 |
DisclosureSEC source: 0000926282-20-000020 · primary_doc.xml · nonDerivative · entry 1 Centis Ronald · CIK 0001769038 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,772.682 F1 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock. Read SEC document |
| June 09, 2020 Filed Sep 16, 2020 15:49 UTC |
Harris RayChief Information Officer
|
GrantCommon Stock | 2.542 | $11.78 | $29.94 |
DisclosureSEC source: 0000926282-20-000019 · primary_doc.xml · nonDerivative · entry 2 Harris Ray · CIK 0001766181 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,938.18 F1 · security: Reflects shares acquired through the automatic reinvestment of dividends paid on the Company's common stock. Read SEC document |
| June 04, 2020 Filed Jun 5, 2020 11:02 UTC |
NICHOLS ROY JDirector
|
GrantDividend Equivalent Rights · Derivative | 72.031 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000002 · primary_doc.xml · derivative · entry 1 NICHOLS ROY J · CIK 0000937725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174.143 Underlying: Common Stock · 72.031 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| June 04, 2020 Filed Jun 5, 2020 20:58 UTC | GrantDividend Equivalent Rights · Derivative | 131.571 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000010 · primary_doc.xml · derivative · entry 2 Foliano Michael · CIK 0001300513 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,223.731 Underlying: Common Stock · 131.571 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock at the cash value thereof. F3 · derivative.exercise_date: Phantom stock held in a deferred compensation plan by the Reporting Person, which becomes payable six months after the Reporting Person's separation of service with the Company. The Reporting Person may transfer the phantom stock into an alternative investment at any time. F3 · derivative.expiration_date: Phantom stock held in a deferred compensation plan by the Reporting Person, which becomes payable six months after the Reporting Person's separation of service with the Company. The Reporting Person may transfer the phantom stock into an alternative investment at any time. Read SEC document |
|
| June 04, 2020 Filed Jun 5, 2020 20:58 UTC | GrantCommon Stock | 1.794 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000010 · primary_doc.xml · nonDerivative · entry 1 Foliano Michael · CIK 0001300513 · CFO 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) plan Disclosed balance after: 237.834 F1 · security: Dividends reinvested into common stock and held in 401(k) plan by Reporting Person. Read SEC document |
|
| June 04, 2020 Filed Jun 5, 2020 19:44 UTC |
Wilson James Denson JrChief Revenue Officer
|
GrantPhantom Stock · Derivative | 125.866 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000009 · primary_doc.xml · derivative · entry 1 Wilson James Denson Jr · CIK 0001371377 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,476.821 Underlying: Common Stock · 125.866 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock at the cash value thereof. F2 · derivative.exercise_date: Phantom stock held in a deferred compensation plan by the Reporting Person, which becomes payable six months after the Reporting Person's separation of service with the Company. The Reporting Person may transfer the phantom stock into an alternative investment at any time. F2 · derivative.expiration_date: Phantom stock held in a deferred compensation plan by the Reporting Person, which becomes payable six months after the Reporting Person's separation of service with the Company. The Reporting Person may transfer the phantom stock into an alternative investment at any time. Read SEC document |
| June 04, 2020 Filed Jun 5, 2020 19:09 UTC |
STANTON THOMAS RChairman and CEO
|
GrantPhantom Stock · Derivative | 748.72 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000008 · primary_doc.xml · derivative · entry 1 STANTON THOMAS R · CIK 0001191219 · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,013.435 Underlying: Common Stock · 748.72 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock represents a right to receive one share of common stock at the cash value thereof. F2 · derivative.exercise_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time. F2 · derivative.expiration_date: The phantom stock becomes payable six months after the reporting person's separation of service with the Company. The reporting person may transfer the phantom stock account into an alternative investment at any time. Read SEC document |
| June 04, 2020 Filed Jun 5, 2020 18:20 UTC |
McCray Gregory JamesDirector
|
GrantDividend Equivalent Rights · Derivative | 72.031 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000007 · primary_doc.xml · derivative · entry 1 McCray Gregory James · CIK 0001327057 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174.143 Underlying: Common Stock · 72.031 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| June 04, 2020 Filed Jun 5, 2020 17:59 UTC |
Jacqueline Hourigan RiceDirector
|
GrantDividend Equivalent Rights · Derivative | 72.031 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000006 · primary_doc.xml · derivative · entry 1 Jacqueline Hourigan Rice · CIK 0001637150 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174.143 Underlying: Common Stock · 72.031 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| June 04, 2020 Filed Jun 5, 2020 16:55 UTC |
Walker Kathryn ADirector
|
GrantDividend Equivalent Rights · Derivative | 72.031 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000005 · primary_doc.xml · derivative · entry 1 Walker Kathryn A · CIK 0001264261 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174.143 Underlying: Common Stock · 72.031 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
| June 04, 2020 Filed Jun 5, 2020 16:00 UTC |
Nair BalanDirector
|
GrantDividend Equivalent Rights · Derivative | 72.031 | $0.00 | $0.00 |
DisclosureSEC source: 0000926282-20-000004 · primary_doc.xml · derivative · entry 1 Nair Balan · CIK 0001398905 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174.143 Underlying: Common Stock · 72.031 shares Expires not disclosed F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.exercise_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. F1 · derivative.expiration_date: Settlement of dividend equivalent rights in connection with the vesting of restricted stock units. The rights accrue when and as dividends are paid on the Company's common stock and are paid in whole shares of common stock with the remainder paid in cash. Each dividend equivalent right is the equivalent of one share of the Company's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.